JPRN-UMIN000035416招募中未知
Efficacy, safety, and pulmonary functions of bronchial thermoplasty in patients with severe asthma - Efficacy, safety, and pulmonary functions of bronchial thermoplasty in patients with severe asthma
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Malignant tumors 2)Severe heart disease 3)Severe hepatic failure 4)Severe renal failure (serum creatinine levels 2.0 or more mg/dl) 5)Current use of a body defibrillator, such as pacemaker or implantable cardioverter defibrillator 6)Active infectious disease 7)Exacerbation of asthma or change in the drug regimen to include oral corticosteroids in the past 14 days 8)Change in the maintenance drug therapy for bronchial asthma in the past 4 weeks 9)Less than 65% post-bronchodilator %FEV1 10)Uncontrolled sinusitis 11)Requirement for oral steroid that is equivalent to more than 10 mg/day of prednisone to control bronchial asthma 12)Past history of intubation or admission to the intensive care unit due to bronchial asthma in the past 24 months 13)Past history in the past 12 months as follows; i) 4 or more infections of the lower respiratory tract, or ii) 3 or more admissions due to respiratory symptoms 14)Has smoked in the past 12 months or has a smoking history of 10 or more pack-years 15)Has previously undergone bronchial thermoplasty 16)Pregnancy or potential pregnancy 17)Judged inadequate to participate in the study by their physicians
研究者
相似试验
已完成
不适用
Evaluation of Broncho-Vaxom(R) ability to respond to the induction of inflammation through the inhalation of a bacterial componentRespiratoryBronchitis, not specified as acute or chronicBronchitisISRCTN25212012OM Pharma [Vifor Pharma] (Switzerland)60
进行中(未招募)
不适用
Evaluation of Broncho-Vaxom(R) ability to respond to the induction of inflammation through the inhalation of a bacterial component.Participants of the study will be assigned by chance to one of the treatment arms and Broncho-Vaxom(R) will be compared to a product with no treatment value (placebo). Neither the participants nor the study staff will know which subject receive Broncho-Vaxom(R) or the placebo.EUCTR2012-000712-29-DEOM Pharma SA
招募中
2 期
Examination of safety and efficacy of pulmonary rehabilitation for patients with pulmonary hypertension: Appropriate exercise prescription on pulmonary hypertension during exercisepulmonary hypertensionJPRN-jRCT1030210240Sugiura Toshihiko21
招募中
不适用
A study of safety and efficacy of bronchoscope biopsy with a Cryoprobe.ung tumor, Diffuse interstitial lung diseaseJPRN-UMIN000034546International University of Health and Welfare, Mita hospital150
招募中
不适用
Inhaled Amikacin for Ventilator Associated Pneumonia (VAP)Kidney DiseasePACTR201909502649249Faculty of Medicine Alexandria University45
